Navigation Links
New High Purity Immunoglobulin Enters Phase III in Europe and the US
Date:2/16/2010

LACHEN, Switzerland, February 16 /PRNewswire/ --

- Octapharma to Set New Standards in IVIG Development, Focused on Improving Outcomes For Patients and Physicians

Octapharma AG today announced the start of the first of a series of Phase III studies for its new 10% high purity intravenous immunoglobulin (IVIG). The study will investigate the efficacy and safety of this novel immunoglobulin in the treatment of primary immune deficiency and, together with results from additional upcoming studies, will support its regulatory filing in Europe and the US.

Commenting on the start of the study, Kim Björnstrup, Deputy Chairman of Octapharma Group said, "The development of our novel 10% IVIG is part of our ongoing commitment to invest in the development of protein based immunotherapies and in particular in IgG preparations. For 25 years, our cutting-edge research programme has sought to develop new biological entities tailored specifically around the needs of clinicians and patients - delivering improved quality of life for patients and ease of delivery and management for hospitals."

"Octapharma's stated aim is not to develop just another IVIG brand but to invest extensive time and preclinical resources to ensure that the new IVIG will offer outstanding features, representing tangible added value for the patient and care giver, such as exceptional tolerability," added Kim Björnstrup.

The development of this pioneering high purity IVIG builds upon Octapharma's experience in the area of immunoglobulin products. octagam(R), Octapharma's current leading IVIG (an immune globulin human solution for intravenous administration) is registered in about 60 countries, including the EU and the US.

"Octapharma's new 10% IVIG will be a step fo
'/>"/>

SOURCE Octapharma AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Purity Products Releases Their Next Generation Lycopene Omega-3 Super Formula
2. Purity Products Releases Their Brand New Mediterranean Diet Resveratrol Formula
3. New Reagents from New England Biolabs Bring Purity and Increased Value to Sample Prep for Next Generation Sequencing
4. Purity Products Partners with Leading Vitamin D Expert to Create Next-Generation D3 Complex
5. Diet, Purity of Food Source Could be Keys to Improving Health of Hong Kong Toddlers
6. Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009
7. Experimental Apartment in Beijing Achieves 99% Purity of Indoor Air
8. NSF International Certifies Purity of Four Mannatech Products
9. New technique improves purity of medicines
10. Immunoglobulin Can Predict Some Diabetic Complications
11. Minorities Not Treated at Higher-Quality Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... Move over shave cream. ... men and barbershops are scrambling to meet it. , Reports published this year (Mintel ... and haircare. But the data also reflects that men are getting more done at ...
(Date:8/31/2015)... ... 2015 , ... A year ago this month, Seniors Guide first hit stands ... issue commemorating the successful first year. , “We started the magazine with the ... in their lives,” says Melissa Wolfert, founding Publisher for Seniors Guide Columbus. “Making the ...
(Date:8/31/2015)... ... 2015 , ... Chicago-based company The Mood Factory, with brand ... and awareness for breast and ovarian health. During September and October, The ... to Bright Pink® to encourage households, dorms, and offices around the U.S. to ...
(Date:8/31/2015)... ... ... It’s a lot like coming home. Life-long Fox Valley resident James Holbrook has been ... the job, he’s run into residents of the retirement community who he’s known since ... in such a wonderful place,” he said. GreenFields, which is sponsored by Friendship Senior ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... networking and relationship-marketing firm, announced today the nominees vying for the 2015 ... U.S. Region. Executives include top-ranking decision makers representing national to global organizations ...
Breaking Medicine News(10 mins):Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 2Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 3Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 3Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 2Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 3Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:T.E.N. Announces Nominees for the 2015 ISE® Northeast Awards; People's Choice voting now open 2Health News:T.E.N. Announces Nominees for the 2015 ISE® Northeast Awards; People's Choice voting now open 3Health News:T.E.N. Announces Nominees for the 2015 ISE® Northeast Awards; People's Choice voting now open 4
... New research has found that hormone therapy used to treat ... chance of developing various heart problems. Some choices of therapy ... Researchers told Europe,s biggest cancer congress, ECCO 15 ESMO ... findings of their study, the largest and most comprehensive to ...
... , MAHWAH, N.J., Sept. 22 Radware ... application delivery solutions for business-smart networking, today announced ... and South Carolina, has leveraged Radware,s suite of application delivery solutions ... load balancing capabilities for its extensive hospital system. ...
... , , RANDOLPH, Mass., Sept. 22 ... to serving individuals with Autism Spectrum Disorders (ASD), today released its ... and adolescents with ASD ever published. , , ... information about the myriad treatments available for ASD," said Susan M. ...
... Germany, September 22 The,Gerresheimer Group expands its ... significant investments in the USA and,Europe. This week ... research,and development center for medical plastic systems in ... for pharmaceutical plastic packaging in Spain.,"Plastics are increasingly ...
... Corrie Yackulic, ... after nearly twenty years to open her own personal injury law practice. , ... Seattle, Wash. (Lexis Nexis) September 22, 2009 ... at personal injury law firm Schroeter Goldmark & Bender to launch her own personal injury ...
... ... Pelvic Organ Prolapse --provides helpful information about the common conditions of urinary incontinence and ... symptoms, as well as the symptoms of pelvic organ prolapse. Finally, treatment options are ... ...
Cached Medicine News:Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 2Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 3Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 4Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 2Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 3Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 4Health News:Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S. 5Health News:National Autism Center Releases Groundbreaking Report on Autism Treatments 2Health News:National Autism Center Releases Groundbreaking Report on Autism Treatments 3Health News:Gerresheimer Expands in the Global Pharmaceutical Plastic Business 2Health News:Gerresheimer Expands in the Global Pharmaceutical Plastic Business 3Health News:Seattle Personal Injury Attorney Corrie Yackulic Opens Law Firm, Unveils New Website 2Health News:Women's Pelvic Organ Prolapse and Incontinence Guide Informs, Outlines Treatments 2Health News:Women's Pelvic Organ Prolapse and Incontinence Guide Informs, Outlines Treatments 3
(Date:8/31/2015)... 31, 2015 BioLight ... BLGTY) ("BioLight" or the "Company"), a firm that ... ophthalmology and cancer diagnostics, today announced that its ... identified several new genetic markers with high potential ... treated with bisphosphonate drugs and was able to ...
(Date:8/31/2015)... 31, 2015  Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today it has completed enrollment of the additional ... (DRC) earlier this year, into the company,s Phase ... innate defense regulator (IDR) and is being evaluated ...
(Date:8/31/2015)... , Aug. 31, 2015  Asterias Biotherapeutics, Inc. ... the emerging field of regenerative medicine, today announced ... Chicago -based Rush University Medical ... activity of escalating doses of AST-OPC1 (oligodendrocyte progenitor ... motor complete cervical spinal cord injury (SCI). This ...
Breaking Medicine Technology:BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6
... experienced,clinical benefit when treated with daily RAD001 and monthly Sandostatin LAR ... Depot, - 77% of patients with pancreatic NET experienced clinical ... treated with daily RAD001, - Data show RAD001, an oral mTOR ... ...
... Inc.,(Nasdaq: BNVI ) today announced the publishing ... Society for Pharmacology and Experimental Therapeutics, Drug,Metabolism and ... Bioactive Compound Isolated from the Chinese Herbal,Selective Estrogen ... the active compounds of MF101, Bionovo,s drug,candidate for ...
Cached Medicine Technology:RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 2RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 3RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 4RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 5RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 6RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors 7Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 3
BETADINE® Surgical Scrub is a microbicidal, sudsing cleanser that promptly kills most bacteria, fungi, viruses, protozoa and yeasts. It is indicated for hand hygiene, surgical hand-scrubbing, an...
... Topical, Bactericide, Microbicide for professional ... technology in skin disinfectants combining quaternary ... a synergistic blend of emollients and ... and gram-positive organisms tested in 30 ...
... bonds with the skin ... germ-killing field. In addition ... antimicrobial effect, HIBICLENS' non-drying, ... promotes compliance with the ...
... solution, allows the user to prep one ... in less than 2-minutes. It also utilizes ... surgical scrubbing and healthcare personnel handwashing. ACTIPREP ... provide a tacky surface for drapes to ...
Medicine Products: